To the Editor: The incidence of influenza A (H1N1) viruses thatcarry the neuraminidase H274Y mutation has increased by 30%this year in the Netherlands.1 Influenza A (H1N1) viruses thatcarry this mutation are resistant to oseltamivir but remainsensitive to zanamivir.2 However, these mutant viruses are consideredto have attenuated pathogenicity.3,4
A 67-year-old man who had received a diagnosis of chronic lymphocyticleukemia 3 years earlier was admitted to the hospital becauseof dyspnea, dry cough, and fever. One week before admission,he had received a course of cyclophosphamide, vincristine, andprednisolone chemotherapy. At admission, his white-cell countwas . . . [Full Text of this Article]
This article has been cited by other articles:
Nguyen, J. T., Hoopes, J. D., Smee, D. F., Prichard, M. N., Driebe, E. M., Engelthaler, D. M., Le, M. H., Keim, P. S., Spence, R. P., Went, G. T.
(2009). Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro. Antimicrob. Agents Chemother.
53: 4115-4126
[Abstract][Full Text]
Dharan, N. J., Gubareva, L. V., Meyer, J. J., Okomo-Adhiambo, M., McClinton, R. C., Marshall, S. A., St. George, K., Epperson, S., Brammer, L., Klimov, A. I., Bresee, J. S., Fry, A. M., for the Oseltamivir-Resistance Working Group,
(2009). Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States. JAMA
301: 1034-1041
[Abstract][Full Text]
Gooskens, J., Jonges, M., Claas, E. C. J., Meijer, A., van den Broek, P. J., Kroes, A. C. M.
(2009). Morbidity and Mortality Associated With Nosocomial Transmission of Oseltamivir- Resistant Influenza A(H1N1) Virus. JAMA
301: 1042-1046
[Abstract][Full Text]